# Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma

> **NCT05912582** · — · NOT_YET_RECRUITING · sponsor: **Jiangsu Cancer Institute & Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **RADIATION:** Intensity modulated radiation therapy (IMRT) combined with chemotherapy

## Key facts

- **NCT ID:** NCT05912582
- **Lead sponsor:** Jiangsu Cancer Institute & Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-25
- **Primary completion:** 2027-06-25
- **Final completion:** 2028-12-25
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05912582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05912582, "Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05912582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*